NeuroSense Therapeutics Ltd. Ordinary Shares (NASDAQ: NRSN) last traded at $3.48, down 4.92% on the session. The quote above updates while this page is open; the figures below are drawn from NeuroSense Therapeutics Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
NeuroSense Therapeutics Ltd. Ordinary Shares trades on NASDAQ under the ticker NRSN. Its market capitalisation is $113.30 million.
Valuation measures for NeuroSense Therapeutics Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $113.30M |
|---|---|
| Enterprise value | $115.72M |
| Beta | 2.82 |
Trailing-twelve-month figures tagged in NeuroSense Therapeutics Ltd. Ordinary Shares's XBRL filings with the SEC.
| Net income (TTM) | -$11.13M |
|---|
| EPS (TTM) | -$0.440 |
|---|
| Cash | $166.0K |
|---|
Range and volume for NRSN over the past 52 weeks.
| 52-week high | $26.64 |
|---|---|
| 52-week low | $3.28 |
| Volume | 6.2K |
| Average volume | 266.1K |
| Previous close | $3.66 |
Invest a chosen dollar amount in NeuroSense Therapeutics Ltd. Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NRSN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.